FDA Approved: MYXREDLIN — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved a supplemental application for MYXREDLIN (insulin human) from Baxter Healthcare Corporation, authorizing changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• MYXREDLIN (INSULIN HUMAN)

Snippet

SUPPL AP for MYXREDLIN (INSULIN HUMAN)